Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...
In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...
Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...
For years, health researchers have been talking about the potential of real-world data (RWD) to revolutionize every stage of clinical research, from trial design to outcomes measurement. Healthcare ...
New Approach to Clinical Trial Design Helps Medical Devices Better Meet Patient Needs and Priorities
ARLINGTON, Va.--(BUSINESS WIRE)--A Medical Device Innovation Consortium (MDIC) program today released a new framework that provides U.S. medical device companies a systematic approach for ...
In a recent perspective published in Nature Medicine, the researcher shared his vision and future perspectives for the domains of clinical research and evidence-based therapeutics. In recent times, ...
BOSTON, Mass. – January 11, 2021 – NEJM Group today announces the launch of a new digital journal, NEJM Evidence, coming at a time when research transparency is being openly discussed in the medical ...
Forbes contributors publish independent expert analyses and insights. Greg Licholai writes and teaches about innovation in healthcare. Health technology startup HumanFirst is changing the way clinical ...
For decades, academic clinical trials consortia have collaborated to optimize outcomes for childhood cancers through evaluating incremental improvements in conventional mutimodality treatment regimes.
BHF has introduced a policy on diversity in research design, setting clearer expectations that, wherever possible, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results